S.-T. Wang, et al.
PhytochemistryLetters34(2019)99–102
3. Material and methods
3.1. General experimental procedures
Optical rotations were recorded using a Rudolph Autopol IV–T au-
tometic polarimeter (Rudolph Research Analytical, USA). UV spectra
were measured on a U–2900 spectrophotometer (Hitachi, Japan). IR
spectra were obtained on a Nicolet i5 spectrometer (Thermo Fisher,
USA) with KBr pellets. HRESIMS spectra were recorded on a TripleTOF
5600+ mass spectrometer (Applied Biosystems Sciex, USA). NMR
spectra were recorded on a Bruker Ascend™ 600 MHz spectrometer with
TMS as internal standard. Column chromatography (CC) was performed
using silica gel (200–300 and 300–400 mesh, Qingdao Haiyang
Chemical Co., Ltd., China), HZ818 macroporous resin (HuaZhen
Technology, China), C18 (40–60 μm, Agela Technologies, China), and
Sephadex LH–20 (Amersham Biosciences, Sweden). Fractions were
monitored by TLC using precoated GF254 silica gel plates (Qingdao
Haiyang Chemical Co., Ltd., China) and RP–18 F254S silica gel plates
(Merck KGaA, Germany). Semipreparative HPLC was carried out on an
Fig. 2. Selected 1H–1H COSY
pound 1.
and HMBC (H→C) correlations of com-
LC–15C (Shimadzu, Japan) with
a
Gemini C18 column
(10 mm × 150 mm, 5 μm, Phenomenex, Germany).
3.2. Plant material
The tubers of S. succifera were collected at Wuzhishan, Hainan
Province, China, in 2014, and authenticated by Dr. Yun Kang, Fudan
University. A voucher specimen (2014057 G) has been deposited in the
Department of Pharmacognosy, Fudan University, China.
Fig. 3. Selected 1H–1H COSY
relations of compound 2.
, HMBC (H→C), and ROESY
cor-
3.3. Extraction and isolation
The dried and powdered tubers (5.5 kg) of S. succifera were ex-
tracted with 95% EtOH (50 L) at room temperature. After concentration
under reduced pressure, the crude extract (798 g) were dissolved in
water (2 L) to get a homogeneous dispersion and then partitioned
successively with petroleum ether (PE) and dichloromethane (CH2Cl2)
to afford a PE extract (85 g) and a CH2Cl2 extract (196 g). The re-
maining aqueous solution was applied to an HZ818 macroporous resin
column eluted with EtOH–H2O (95:5, v/v). The EtOH–H2O (95:5) el-
uate (99 g) was chromatographed on a silica gel column (200–300
mesh) with a gradient CH2Cl2–MeOH (15:1, 10:1, 5:1, 2:1, 0:1, v/v) as
eluent to give nine fractions (Fr. A–I). Fr.G was loaded on another
HZ818 macroporous resin column eluted with a gradient MeOH–H2O
(5:5, 6:4, 7:3, 1:0, v/v) to yield subfractions G1–G5. Fr.G3 was sub-
jected to C18 CC eluted with MeOH–H2O (3:7, 4:6, 5:5, 6:4, 1:0, v/v) to
give Fr.G3.1 to Fr.G3.5. Fr.G3.2 was further separated on a Sephadex
LH-20 CC (MeOH) followed by semipreparative HPLC (MeOH–H2O,
45:55, v/v, flow rate 3 mL/min) to yield 2 (5.4 mg) and 7 (10.0 mg).
Fr.G3.3 was purified by Sephadex LH-20 CC (MeOH) and semi-
preparative HPLC (MeOH–H2O, 35:65, v/v, flow rate 3 mL/min) to
yield 13 (2.7 mg). Fr.G4 was subjected to silica gel CC (300–400 mesh)
eluted with a gradient CH2Cl2–MeOH (15:1, 10:1, 8:1. 5:1, v/v) and
further purified by semipreparative HPLC (MeOH–0.05% Et2NH aqu-
eous solution, 40:60, v/v, flow rate 3 mL/min) to give 10 (12.9 mg).
Fr.G5 was purified by Sephadex LH-20 CC (MeOH) and semipreparative
HPLC (MeOH–H2O, 55:45, v/v, flow rate 3 mL/min) to yield 1 (2.4 mg).
Fr.H was subjected to semipreparative HPLC (MeOH–0.02% Et2NH
aqueous solution, 30:70, v/v, flow rate 3 mL/min) to yield 8 (6.8 mg).
Compound 9 (5.1 mg) was obtained from Fr.I using the same procedure
as compound 8. The CH2Cl2 extract was fractionated on a silica gel CC
(200–300 mesh) using a gradient CH2Cl2–MeOH (1:0, 50:1, 20:1, 10:1,
1:1, 0:1, v/v) as eluent to give eight fractions (Fr.J–Q). Fr.L was loaded
on another silica gel CC (300–400 mesh) eluted with a gradient
CH2Cl2–MeOH (30:1, 20:1, 10:1, v/v) to give subfractions L1–L6. Fr.L3
was purified by Sephadex LH-20 CC (MeOH) followed by semi-
preparative HPLC (MeOH–0.02% Et2NH aqueous solution, 88:12, v/v,
nature for the first time, and compounds 4, 5, 7, 8, 11, and 13 are
isolated from S. succifera for the first time.
All isolated compounds were tested for their in vitro antibacterial
activity against MRSA by the broth microdilution method. Vancomycin
was used as a positive control. As shown in Table 2, compounds 5, 6, 8,
and 10 showed antimicrobial activity against MRSA. The lowest
minimum inhibitory concentration (MIC) was observed for compound 6
(128 μg/mL) followed by compounds 5, 8, and 10 (256 μg/mL).
Table 2
Anti-MRSA activities of the compounds isolated from S. succifera.
Compounds
MIC(μg/mL)
manshurienine C (1)
> 256
> 256
> 256
> 256
256
8-oxotetrahy-corydalmine-1-O-β-D-glucopyranoside (2)
secocrebanine (3)
norcrebanine (4)
8-hydroxy-9-methoxy-1,2-methylenedioxyaporphine (5)
crebanine (6)
128
N-formyl-asimilobine-2-O-β-D-glucopyranoside (7)
asimilobine-2-O-β-D-glucopyranoside (8)
N-methylasimilobine-2-O-β-D-glucopyranoside (9)
asimilobine (10)
> 256
256
> 256
256
liriodenine (11)
> 256
> 256
> 256
0.5
4-hydroxycrebanine (12)
trans-feruloyl-(3-O-methyl)-dopamine- 4-O-β-D-glucopyranoside (13)
a
Vancomycin was used as a positive control.
101